Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
104.23
+0.41 (0.39%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $5.08 billion as of April 24, 2025. Its market cap has increased by 48.50% in one year.
Market Cap
5.08B
Enterprise Value
4.96B
1-Year Change
48.50%
Ranking
Category
Stock Price
$104.23
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $5.08B, an increase of 3,181.35%. That is a compound annual growth rate of 44.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 5.06B | 23.47% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.51B |
| UnitedHealth Group | 386.70B |
| Johnson & Johnson | 380.25B |
| AbbVie | 306.99B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.25B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |